ADC Therapeutics

Bridges - Advances in Cancer Therapeutics

Health EN ↓ 4 episodes

Bridges is a new educational podcast miniseries where co-hosts, Dr. Matthew Lunning and Dr. Tara Graff, bring together voices from across the lymphoma care spectrum. Each episode features candid conversations with a diverse range of clinicians, offering practical insights into current topics in lymphoma.  With Dr. Graff practicing in the community setting at Mission Cancer & Blood and Dr. Lunning in academic medicine at the University of Nebraska, Bridges explores the dynamic between academic and community approaches—working to close the gap  and foster collaboration in patient care. This epis...

Author

ADC Therapeutics

Episodes

Episode 4 - Guiding principles when sequencing treatments in DLBCL 24.11.2025 17:46

Gain practical insights into treatment sequencing in the evolving DLBCL landscape. In this episode, Dr. Marin Xavier shares her approach to navigating novel therapies—such as antibody drug conjugates (ADCs) and bispecifics—with a focus on patients who may not be ready for CAR T-cell therapy. Learn how she makes real-world decisions in a complex and rapidly changing field. Co-hosts: Dr. Matthew Lun...

Episode 3 - Managing novel DLBCL therapies in the community - what good looks like 24.11.2025 16:09

Integrating novel therapies like bispecific antibodies (BsAbs) and antibody drug conjugates (ADCs) into community oncology practices can be a complex process. On this episode of Bridges, Dr. Lunning and Dr. Graff speak with Dr. Iqra Choudary about how she integrated BsAbs and ADCs into her practice with a proactive multidisciplinary team, strong safety protocols, comprehensive staff training, and...

Episode 2 - The future is now-combination therapies in DLBCL 24.11.2025 18:09

Interested in novel combination therapies for patients with diffuse large B-cell lymphoma (DLBCL)? Dr. Marie Hu joins the podcast to share her perspectives on emerging treatments and the impact of stronger academic-community collaborations on patient care for relapsed and refractory patients with DLBCL. Co-hosts: Dr. Matthew Lunning, MD, University of Nebraska Medical Center, and Dr. Tara Graff, M...

Episode 1 - Evolution of Antibody Drug Conjugates 24.11.2025 17:51

Join us for a high-level look at antibody drug conjugates (ADCs) in lymphoma treatment. Dr. Weiyun Ai provides a detailed overview of ADCs—a pioneering method that can change how lymphoma is treated. Learn how they target cancer, overcome obstacles, and pave the way for developing new combination therapies. Co-hosts: Dr. Matthew Lunning, MD, University of Nebraska Medical Center, and Dr. Tara Graf...